Condition: Leptomeningeal Metastasis of Breast Cancer · Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Traditional clinical trials in patients with breast cancer leptomeningeal disease (LMD) are challenging as patients often have a rapidly progressive course and prognosis is poor, making meeting standard eligibility difficult. Furthermore, there is limited information about the biology of LMD. The investigators thus propose a study that is as inclusive as possible, which will allow the investigators to collect biospecimens and clinical outcomes to learn more about LMD biology, but still potentially provide benefit for patients, by providing patients rapid diagnostics and multi-disciplinary treatment recommendations.
This description comes directly from the study's public registry record.
Hopkins Breast Trials · 410-614-1361 · HopkinsBreastTrials@jhmi.edu
Sidney Kimmel Cancer Center Clinical Research Office · 410-955-8866 · jhcccro@jhmi.edu
Always discuss trial participation with your own doctor first.
| Sibley Memorial Hospital | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06638294